Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2024-02-19 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a board meeting to approve and publish the interim results for the six months ended 31 December 2023. It does not contain the interim financial report itself but rather informs about the upcoming board meeting and the expected approval and publication of the interim results. The document is short (2392 characters) and serves as a notice rather than a full financial report. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2024-02-19 English
INSIDE INFORMATION FURTHER ADJOURNMENT OF WINDING-UP PETITION HEARING
Legal Proceedings Report Classification · 95% confidence The document is an announcement made pursuant to the GEM Listing Rules and Inside Information Provisions regarding the adjournment of a winding-up petition hearing. It references previous announcements and provides an update on the legal proceeding timeline. The document is short (3206 characters) and does not contain financial statements or detailed financial data. It is clearly an announcement about a legal proceeding update rather than a full legal proceedings report or financial report. Therefore, it fits best under Legal Proceedings Report (LTR).
2024-02-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return on movements in securities for Sinopharm Tech Holdings Limited, including authorized and issued share capital, share options, and confirmations related to share issuance. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. The content focuses on share capital changes, share options, and confirmations of authorization by the board. There is no financial performance data, earnings information, or management discussion. The document is regulatory in nature, reporting share capital movements and confirmations, which aligns with a Major Shareholding Notification or Share Issue/Capital Change. Given the detailed share capital and share option movements, it fits best under Share Issue/Capital Change (SHA). The document is not a simple announcement but a formal regulatory return with substantive data on share capital changes.
2024-02-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, and confirmations related to securities issued during the month ended 31 December 2023. The content focuses on share capital changes, share options, and compliance confirmations rather than financial performance, earnings, or management commentary. It is a regulatory submission concerning share capital movements and confirmations rather than a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-04 English
ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS AND REPLY FORM
Regulatory Filings Classification · 100% confidence The document is a communication from Sinopharm Tech Holdings Limited to its shareholders regarding the election of means of receipt for future corporate communications. It references the GEM Listing Rules and explains options for shareholders to receive documents such as directors' reports, annual accounts, auditors' reports, interim reports, notices of meetings, listing documents, circulars, and proxy forms either electronically or in printed form. The document includes a reply form for shareholders to select their preferred method of receiving these communications. There is no actual financial data, financial statements, or detailed report content present. Instead, it is an announcement about how shareholders can receive future reports and communications. This fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement related to shareholder communications and does not constitute the report itself or a direct financial disclosure.
2024-01-01 English
ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the election of means of receipt of corporate communications by shareholders. It explains options for shareholders to receive future corporate communications either electronically or in printed form, the process for making elections, and the implications of no response. The document does not contain any financial statements, audit information, management discussion, or detailed financial data. It is a regulatory announcement related to shareholder communication preferences and compliance with GEM Listing Rules. It is not a report itself but an announcement about corporate communication arrangements. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-01-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.